Searched for
ASTHMA AND DIABETES CONTROL
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
WHO shares AC-and-fan cooling formula for your room that can cut electricity bill by 70% and give comfortable sleep as wellThe World Health Organization has shared a simple cooling method to help people stay comfortable during rising heat while also reducing ele...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
Comedian Bharti Singh reveals how she lost 15-20 kgs: Check her weight loss dietBharti Singh, the popular comedian and television personality, has undergone an inspiring weight loss transformation, shedding 15-20 kg ove...
'Every resident of Delhi is developing lung damage,' says Anurag Agrawal, Dean, Biosciences and Health research at Ashoka UniversityAnurag Agrawal, dean of biosciences at Ashoka University, warns that the current pollution levels in Delhi are causing lung damage to all r...
Study links air pollution to Type 2 Diabetes risk in IndiaThe 15-year study published in the British Medical Journal (BMJ) included over 12,000 residents from Delhi and Chennai. The researchers fou...
NPPA revises ceiling prices of 128 formulationsThe National Pharmaceutical Pricing Authority (NPPA) has also fixed the retail price of 12 scheduled formulations under Drugs (Prices Contr...
Believe it or not, your food & pollen allergies may be protecting you from catching CovidNew research said that people with atopic diseases have 25% lower odds of contracting Covid.
Obesity main reason in women over 35 for poor diabetes control & increased heart disease risk, says studyThe Apollo study said that diabetes was high in southern, eastern parts of the country.
Chronic health conditions may increase suicide riskConditions such as back pain, diabetes and heart disease may be at an increased risk of committing suicide.
World Asthma Day: Long-term usage of inhalers can have adverse side effectsNot only prevalent in developed countries, but it is also a major problem in the developing countries.
Health ministry to roll out screening & control programme of 5 non-communicable diseasesIn the first phase, the population based screening component will be rolled out in 100 districts in 32 states and UTs with about 1,000 sub-...
NeoBiocon partners Novartis to launch diabetes drugs in UAENeoBiocon has received approvals from the Ministry of Health-UAE for marketing Jalra and Jalra-M in the country and the launch is scheduled...
NPPA brings 39 more drugs under price controlThe prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformin+Glimepiride have been ...
NPPA fixes price of 39 drug formulation packsAs per the notification the prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformi...
Pharmaceutical companies like Ranbaxy Laboratories, Sanofi India and others fume at price control orderOn Friday, the National Pharmaceutical Pricing Authority (NPPA) slashed the prices of 108 brands under a provision of the Drug Pricing Cont...
80% of medicines not covered by price control orderThe much-awaited drug price control order (DPCO) 2013, meant to control the price of medicines does not cover over 80% of the medicines in ...
- GSK signs outsourcing deal with TCS
GSK already has sizeable research operations in Mumbai and Bangalore and employs 2,400 people in India.